18 Among PDE5 inhibitor users in our study, those diagnosed with melanoma had a higher socioeconomic status and a lower comorbidity burden than PDE5 inhibitor users not diagnosed with melanoma. In contrast to most other drugs in Sweden, PDE5 inhibitors are not subsidized. However, even men with multiple filled prescriptions for vardenafil or Fildena, with a longer half-life, did not have a signifi